| Symbol |
Name |
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
ACADM
|
acyl-CoA dehydrogenase, C-4 to C-12 straight chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGXT2
|
alanine--glyoxylate aminotransferase 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDOB
|
aldolase B, fructose-bisphosphate
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOC1
|
apolipoprotein C-I
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP4
|
aquaporin 4
|
|
ARSA
|
arylsulfatase A
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA9
|
carbonic anhydrase IX
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD163
|
CD163 molecule
|
|
CD274
|
CD274 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CLEC10A
|
C-type lectin domain family 10, member A
|
|
CLPX
|
caseinolytic mitochondrial matrix peptidase chaperone subunit
|
|
CMPK1
|
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CSK
|
c-src tyrosine kinase
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DCK
|
deoxycytidine kinase
|
|
DCN
|
decorin
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF4A3
|
eukaryotic translation initiation factor 4A3
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ENG
|
endoglin
|
|
EPHA4
|
EPH receptor A4
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV1
|
ets variant 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FBLN5
|
fibulin 5
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FGB
|
fibrinogen beta chain
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXA1
|
forkhead box A1
|
|
FOXE1
|
forkhead box E1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FST
|
follistatin
|
|
FTO
|
fat mass and obesity associated
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
GALNT9
|
polypeptide N-acetylgalactosaminyltransferase 9
|
|
GATA3
|
GATA binding protein 3
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDF15
|
growth differentiation factor 15
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH2
|
growth hormone 2
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLA
|
galactosidase, alpha
|
|
GPC3
|
glypican 3
|
|
GPR119
|
G protein-coupled receptor 119
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRM4
|
glutamate receptor, metabotropic 4
|
|
GRN
|
granulin
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H3F3A
|
H3 histone, family 3A
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HDAC8
|
histone deacetylase 8
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMHB1
|
histocompatibility (minor) HB-1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HOXA7
|
homeobox A7
|
|
HP
|
haptoglobin
|
|
HPX
|
hemopexin
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL21
|
interleukin 21
|
|
IL24
|
interleukin 24
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
INS
|
insulin
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK2
|
Janus kinase 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KISS1R
|
KISS1 receptor
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LACRT
|
lacritin
|
|
LEP
|
leptin
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPIN1
|
lipin 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC4R
|
melanocortin 4 receptor
|
|
MEFV
|
Mediterranean fever
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR10B
|
microRNA 10b
|
|
MIR126
|
microRNA 126
|
|
MIR151A
|
microRNA 151a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MPO
|
myeloperoxidase
|
|
MSX2
|
msh homeobox 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NELL1
|
NEL-like 1 (chicken)
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPAS2
|
neuronal PAS domain protein 2
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NRG1
|
neuregulin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
OCLN
|
occludin
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PDCD1
|
programmed cell death 1
|
|
PGR
|
progesterone receptor
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLP1
|
proteolipid protein 1
|
|
PNLIP
|
pancreatic lipase
|
|
POLM
|
polymerase (DNA directed), mu
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPM1K
|
protein phosphatase, Mg2+/Mn2+ dependent, 1K
|
|
PRKCB
|
protein kinase C, beta
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTRH2
|
peptidyl-tRNA hydrolase 2
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
|
REG1B
|
regenerating islet-derived 1 beta
|
|
REN
|
renin
|
|
RNU1-4
|
RNA, U1 small nuclear 4
|
|
RRM2
|
ribonucleotide reductase M2
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1D
|
sodium channel, non voltage gated 1 delta subunit
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SEZ6L
|
seizure related 6 homolog (mouse)-like
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPC
|
surfactant protein C
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCAIP
|
synuclein, alpha interacting protein
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPARCL1
|
SPARC-like 1 (hevin)
|
|
ST2
|
suppression of tumorigenicity 2
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STMN1
|
stathmin 1
|
|
SYCN
|
syncollin
|
|
TBX21
|
T-box 21
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TF
|
transferrin
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TH
|
tyrosine hydroxylase
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TKTL1
|
transketolase-like 1
|
|
TLR5
|
toll-like receptor 5
|
|
TMPRSS15
|
transmembrane protease, serine 15
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNXB
|
tenascin XB
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TYMS
|
thymidylate synthetase
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UPRT
|
uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YAP1
|
Yes-associated protein 1
|
